NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Morphic Holding Inc (NASDAQ: MORF)
MORF Technical Analysis
5
As on 9th Jun 2023 MORF STOCK Price closed @ 61.73 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 32.37 & Strong Buy for SHORT-TERM with Stoploss of 43.29 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MORFSTOCK Price
Open | 62.21 | Change | Price | % |
High | 63.00 | 1 Day | -0.38 | -0.61 |
Low | 61.21 | 1 Week | 4.23 | 7.36 |
Close | 61.73 | 1 Month | 15.20 | 32.67 |
Volume | 375200 | 1 Year | 13.09 | 26.91 |
52 Week High 61.57 | 52 Week Low 19.74 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
MORF Daily Charts |
MORF Intraday Charts |
Whats New @ Bazaartrend |
MORF Free Analysis |
|
MORF Important Levels Intraday
RESISTANCE | 65.18 |
RESISTANCE | 64.07 |
RESISTANCE | 63.39 |
RESISTANCE | 62.71 |
SUPPORT | 60.75 |
SUPPORT | 60.07 |
SUPPORT | 59.39 |
SUPPORT | 58.28 |
MORF Forecast May 2024
4th UP Forecast | 83.12 |
3rd UP Forecast | 76.26 |
2nd UP Forecast | 72.02 |
1st UP Forecast | 67.78 |
1st DOWN Forecast | 55.68 |
2nd DOWN Forecast | 51.44 |
3rd DOWN Forecast | 47.2 |
4th DOWN Forecast | 40.34 |
MORF Weekly Forecast
4th UP Forecast | 75.47 |
3rd UP Forecast | 71.06 |
2nd UP Forecast | 68.34 |
1st UP Forecast | 65.62 |
1st DOWN Forecast | 57.84 |
2nd DOWN Forecast | 55.12 |
3rd DOWN Forecast | 52.40 |
4th DOWN Forecast | 47.99 |
MORF Forecast2024
4th UP Forecast | 146.07 |
3rd UP Forecast | 119.02 |
2nd UP Forecast | 102.3 |
1st UP Forecast | 85.58 |
1st DOWN Forecast | 37.88 |
2nd DOWN Forecast | 21.16 |
3rd DOWN Forecast | 4.44 |
4th DOWN Forecast | -22.61 |
Morphic Holding Inc ( NASDAQ USA Symbol : MORF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MORF Other Details
Segment | EQ | |
Market Capital | 2137128064.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
MORF Address
MORF Latest News
MORF Business Profile
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and MORF-720 and MORF-627, which is in the preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß1 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is based in Waltham, Massachusetts. Address: 35 Gatehouse Drive, A2, Waltham, MA, United States, 02451
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service